Angewandte
Chemie
DOI: 10.1002/anie.200801811
Organocatalysis
Asymmetric Catalysis: Resin-Bound Hydroxyprolylthreonine
Derivatives in Enamine-Mediated Reactions**
Richard D. Carpenter, James C. Fettinger, Kit S. Lam, and Mark J. Kurth*
Control of relative and absolute stereochemistry with step-
economy[1,2] presents a continuing challenge in organic syn-
thesis.[3] Asymmetric crossed aldols have historically involved
chiral auxiliaries or O-trapped organometallic intermediates;
the latter operate by either a Zimmerman–Traxler or an open
transition-state model.[4] However, auxiliaries lengthen syn-
theses, and organometallics typically require careful control
of reaction conditions and have limited functional-group
tolerance. Enamines, however, predominantly react at the C-
terminus, and generally deliver products under ambient
reaction conditions.[3] The C2-symmetric trans-2,5-dimethyl-
pyrrolidine reagent is used in asymmetric enamine reactions.
However, it suffers from poor efficacy and is scarce. Although
several asymmetric syntheses exist for the preparation of this
reagent,[5] its limited commercial availability suggests that
these lengthy protocols have not impacted supply.[6]
The group of Chandrasekhar was the first to use l-proline
to prepare chromanones (1; Scheme 1)[17] in a method
requiring the use of DMF, owing to the zwitterionic nature
Scheme 1. a) Retrosynthetic analysis of chromanones (1) and the
structures of resin-bound catalyst A,its diastereomer B,and,the off-
resin analogue of A,catalyst C (spheres represent Tentagel resin).
This problem has been somewhat alleviated by proline-
derived organocatalysts, which have been under intense
investigation in recent years and discussed in reports from
the groups of Yamamoto[7] and Miller.[8] Reactions of
supported (both hetero- and homogeneous)[9] and non-
supported[10] organocatalysts have been reviewed. When
applied to aldol condensations, heterogeneous supported
organocatalysts often require high catalyst loading[11] and long
reaction times,[12] while delivering varied enantioselectivi-
ties.[11–13] Non-supported organocatalysts often require
extended reaction times,[14] have strict solvent require-
ments,[15] and produce variable yields.[16]
of proline.[18] Chromanones are medicinally pertinent hetero-
cycles[19] and the chroman parent system has been found in
natural products such as sappone B[20] and robustadial,[21] in
addition to being a bioisostere for the hydantoin moiety.[22]
Indeed, chromanones have many biomedical applications
and, consequently, have received considerable synthetic
attention.[23] The laboratories of Enders, McKervey, and
Scheidt have reported asymmetric preparations of chroma-
nones, however these routes have modest enantioselectiv-
ity,[24] and require advanced precursors.[25,26]
Clearly, there is a need to develop a practical asymmetric
route to optically active chromanones and to advance
asymmetric solid-phase catalysts for enamine-mediated reac-
tions. Herein, we focus on TentaGel-bound (TG-bound)
catalysts to facilitate recoverability and reusability as well as
to expedite syntheses through microwave-assisted reac-
tions.[27,28] We report the synthesis of resin-bound asymmetric
pyrrolidine catalysts A and B (see Scheme 1), with applica-
tions toward the syntheses of optically active chromanones as
well as other enamine-derived molecular targets.
The development of catalyst A is outlined in Table 1. Each
catalyst (A, D–G) is bound to TentaGel resin, which was
chosen for its relative inertness and hydrophilicity. The
catalysts are prepared rapidly by solid-phase peptide synthe-
sis.[29,30a] For catalyst evaluation, the starting materials,
solvent, and relative quantity of catalyst (1 mol%) were
held constant as the catalyst, temperature, and reaction time
were varied. After the time indicated, all the samples were
subjected to microwave irradiation for 11 min at 1108C.[31]
Table 1, Entry 7 shows the reaction conditions and catalyst
(catalyst A) yielding the highest enantiomeric excess (ee).[30b]
An increase in ee is detected as substituents are altered from
[*] R. D. Carpenter,Dr. J. C. Fettinger,Prof. M. J. Kurth
Department of Chemistry
University of California-Davis
Davis,CA 95616 (USA)
Fax: (+1)530-752-8895
E-mail: mjkurth@ucdavis.edu
Prof. K. S. Lam
Division of Hematology/Oncology,Department of Internal Medicine
University of California-Davis Cancer Center
Sacramento,CA 95817 (USA)
[**] This work was supported by the National Science Foundation (NSF;
CHE-0614756) and the National Institute for General Medical
Sciences (GM076151). NMR spectrometers used in this work were
funded in part by the NSF (CHE-0443516 and CHE-9808183). RDC
thanks the American Chemical Society’s Division of Medicinal
Chemistry for Predoctoral Fellowship support (sponsored by Sanofi-
Aventis),the Howard Hughes Medical Institute for their Med into
Grad Fellowship,and UC Davis for their R. Bryan Miller Graduate
Fellowship.
Supporting information for this article is available on the WWW
Angew. Chem. Int. Ed. 2008, 47, 6407 –6410
ꢀ 2008 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
6407